AI assistant
TRINITY BIOTECH PLC — Foreign Filer Report 2021
Sep 17, 2021
35392_ffr_2021-09-17_02446676-76ab-4664-ac65-0fa26e619caa.zip
Foreign Filer Report
Open in viewerOpens in your device viewer
6-K 1 zk2126588.htm 6-K Licensed to: company Document created using EDGARfilings PROfile 7.5.1.0 Copyright 1995 - 2021 Broadridge
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2021
TRINITY BIOTECH PLC
(Name of Registrant)
IDA Business Park
Bray, Co. Wicklow
Ireland
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):_
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):_
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-___
PROfilePageNumberReset%Num%2%- % -%
EXPLANATORY NOTE
Holders of ADSs received the following “Form of Proxy“ and “Information Request“ notifying them of the Annual General Meeting of Trinity Biotech plc. A copy of these documents are filed herewith as Exhibit 99.1 and Exhibit 99.2 and incorporated herein by reference.
- 2 -
EXHIBIT INDEX
| Exhibit | Description |
|---|---|
| 99.1 | Notice of Annual General Meeting |
| 99.2 | Information Request |
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: September 17, 2021 TRINITY BIOTECH PLC (Registrant) By: /s/ John Gillard John Gillard Chief Financial Officer
- 4 -